Expertise in
9
conditions

Raja Atreya

Erlangen, BY, DE 
Expertise in
9
conditions
Erlangen, BY, DE 
OverviewLocationsClinical Research

Overview

Raja Atreya practices in Erlangen, Germany. Atreya is highly rated in 9 conditions, according to our data. Their top areas of expertise are Viral Gastroenteritis, Colitis, Hemorrhagic Proctocolitis, Endoscopy, and Colonoscopy.

Their clinical research consists of co-authoring 274 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Erlangen, BY, Germany
Other Locations
Erlangen
Bayern, BY, Germany
Bayreuth, BY 95445, Germany
Berlin, BE, Germany
Alexander, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3
SB012 for Treatment of Active Ulcerative Colitis: Prospective Multi-centre Randomised Double-blind Placebo-controlled Phase IIa Clinical Trial to Evaluate Efficacy, Pharmacokinetics, Tolerability and Safety of SB012 Enema Administered OD
SB012 for Treatment of Active Ulcerative Colitis: Prospective Multi-centre Randomised Double-blind Placebo-controlled Phase IIa Clinical Trial to Evaluate Efficacy, Pharmacokinetics, Tolerability and Safety of SB012 Enema Administered OD
Enrollment Status: Completed
Publish Date: March 09, 2018
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

274 Total Publications

CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis.
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis.
Journal: The New England journal of medicine
Published: September 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Atreya's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile